Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan eye drops for corneal ulcer scar healing
IRCT20241102063569N1Phase 3Recruiting
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of losartan in corneal fibrosis (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Healing of corneal ulcer scars, Scar changes caused by corneal ulcer and 1 more. Started Nov 2024; status: recruiting.
02
Drugs
losartan
03
Conditions
corneal fibrosis
Beyond the preview
Go deeper on IRCT20241102063569N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241102063569N1.